Becton Dickinson & Co. (BDX) - Life Sciences Revenue
was reported as $1.25B on Mar 31, 2025,
down from $1.30B the previous quarter on Dec 31, 2024
and down from $1.30B one year prior on Mar 31, 2024.
This is a change of -3.86% from the previous quarter and
-4.37% from one year prior.